Amaç: Bu çalışmada, protez göz kullanan hastalarda meibomian bez disfonksiyonunun oküler rahatsızlık nedeni olup olmadığını araştırmayı ve protez gözlerin meibomian bez üzerine etkisini değerlendirmeyi amaçladık. Gereç ve Yöntemler: Çalışmaya protez göz kullanan 24 hasta dâhil edildi. Her iki göz meibomian bez morfolojisi meibografi (Cirius, CSO, İtalya) ile değerlendirildi. Meibomian bezlerin kaybı Evre 0 (kayıp yok), Evre 1 (<%25), Evre 2 (%25-50), Evre 3 (%50-75) ve Evre 4 (>%75) olarak değerlendirildi. İnferior gözyaşı menisküs parametreleri optik koherens tomografi (Optovue, Inc., Fremont, ABD) ile ölçüldü. Kapak kenarı anormallikleri yarıklı lamba biyomikroskop ile muayene edildi. Hastalardan oküler semptomları değerlendiren anketi doldurmaları istendi. Bulgular: Hastaların %50'si kadındı ve yaş ortalaması 52,5±16,8 (18-87) yıldı. Protez gözün göz kapaklarında üst kapak meiboskor 2,4±0,50 (2-3), sağlıklı gözün göz kapaklarında üst kapak meiboskor 1,50±0,58 (1-3) olup protez gözde anlamlı yüksekti (p<0,001). Alt kapak meiboskor ve gözyaşı menisküs yüksekliği açısından 2 grup arasında anlamlı fark saptanmadı (sırasıyla p=0,07, p=0,90). Gözyaşı menisküs derinliği ve gözyaşı menisküs alanı protez gözlerde sağlıklı gözlere göre anlamlı yüksek saptandı (sırasıyla p=0,009, p=0,02). On yıldan uzun süre protez göz kullananlarda ise oküler semptom skoru daha yüksek saptandı (p<0,001). Sonuç: Protez göz kullanan hastalarda sağlıklı göz ile karşılaştırıldığında üst göz kapaklarında önemli meibomian bez kaybı olmaktadır. Meibomian bez disfonksiyonunun tanı ve tedavisi oküler rahatsızlık semptomları olan protez göz kullanıcılarında şikâyetleri azaltabilir.
Anahtar Kelimeler: Kuru göz sendromları; meibomian bez; protez göz
Objective: We aimed to investigate whether meibomian gland dysfunction is the cause of ocular discomfort in patients wearing prosthetic eyes and to evaluate the effect of prosthetic eyes on meibomian gland. Material and Methods: Twenty-four patients wearing prosthetic eyes were included in the study. Meibomian gland morphology of both eyes was evaluated by meibography (Cirius, CSO, Italy). The loss of meibomian glands was evaluated as Stage 0 (no loss), Stage 1 (<25%), Stage 2 (25%-50%), Stage 3 (50%-75%) and Stage 4 (>75%). Inferior tear meniscus parameters were measured by optical coherence tomography (Optovue, Inc., Fremont, USA). The lid margin abnormalities were examined with a slit lamp biomicroscopy. The patients were asked to fill out a questionnaire evaluating ocular symptoms. Results: Fifthy percent of the patients were female and the mean age of the patients was 52.5±16.8 (18-87) years. The upper lid meiboscore was 2.4±0.50 (2-3), in prosthetic eye and 1.50±0.58 (1-3), in healthy eye, which was higher in prosthetic eye (p<0.001). There was no difference between groups in terms of lower lid meiboscore and tear meniscus height (p=0.07, p=0.90 respectively). Tear meniscus depth and tear meniscus area were found to be higher in prosthetic eyes (p=0.009, p=0.02, respectively). Ocular symptom score was found to be higher in those who wore prosthetic eyes for more than 10 years (p<0.001). Conclusion: Compared to healthy eyes, patients wearing prosthetic eyes have significant meibomian gland loss in the upper eyelids. Diagnosis and treatment of meibomian gland dysfunction can alleviate symptoms in prosthetic eye wearers with symptoms of ocular discomfort.
Keywords: Dry eye syndromes; meibomian gland; prosthtetic eye
- Pine K, Sloan B, Stewart J, Jacobs RJ. Concerns of anophthalmic patients wearing artificial eyes. Clin Exp Ophthalmol. 2011;39(1):47-52. [PubMed]
- Pine K, Sloan B, Stewart J, Jacobs RJ. A survey of prosthetic eye wearers to investigate mucoid discharge. Clin Ophthalmol. 2012;6:707-13. [Crossref] [PubMed] [PMC]
- Shapira Y, Worrell E, Litwin AS, Malhotra R. The UK National Artificial Eye Questionnaire study: predictors of artificial eye wearers' experience part 1-comfort and satisfaction. Eye (Lond). 2021;35(8):2233-40. [Crossref] [PubMed] [PMC]
- Nichols KK, Foulks GN, Bron AJ, Glasgow BJ, Dogru M, Tsubota K, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011;52(4):1922-9. [Crossref] [PubMed] [PMC]
- Jang SY, Lee SY, Yoon JS. Meibomian gland dysfunction in longstanding prosthetic eye wearers. Br J Ophthalmol. 2013;97(4):398-402. Erratum in: Br J Ophthalmol. 2013;97(10):1362. [Crossref] [PubMed]
- Pult H, Riede-Pult B. Comparison of subjective grading and objective assessment in meibography. Cont Lens Anterior Eye. 2013;36(1):22-7. [Crossref] [PubMed]
- Jones CA, Collin JR. A classification and review the causes of discharging sockets. Trans Ophthalmol Soc U K. 1983;103 ( Pt 3):351-3. [Crossref] [PubMed] [PMC]
- Allen L, Kolder HE, Bulgarelli EM, Bulgarelli DM. Artificial eyes and tear measurements. Ophthalmology. 1980;87(2):155-7. [Crossref] [PubMed]
- Altin Ekin M, Karadeniz Ugurlu S, Kahraman HG. Meibomian gland dysfunction and its association with ocular discomfort in patients with ocular prosthesis. Eye Contact Lens. 2020;46(5):285-90. [Crossref] [PubMed]
- Wolffsohn JS, Arita R, Chalmers R, Djalilian A, Dogru M, Dumbleton K, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017;15(3):539-74. [Crossref] [PubMed]
- Bandlitz S, Purslow C, Murphy PJ, Pult H. The relationship between tear meniscus regularity and conjunctival folds. Optom Vis Sci. 2014;91(9):1037-44. [Crossref] [PubMed]
- Srinivasan S, Chan C, Jones L. Apparent time-dependent differences in inferior tear meniscus height in human subjects with mild dry eye symptoms. Clin Exp Optom. 2007;90(5):345-50. [Crossref] [PubMed]
- Kim SE, Yoon JS, Lee SY. Tear measurement in prosthetic eye users with fourier-domain optical coherence tomography. Am J Ophthalmol. 2010;149(4):602-7.e1. [Crossref] [PubMed]
- Ko JS, Seo Y, Chae MK, Jang SY, Yoon JS. Effect of topical loteprednol etabonate with lid hygiene on tear cytokines and meibomian gland dysfunction in prosthetic eye wearers. Eye (Lond). 2018;32(2):439-45. [Crossref] [PubMed] [PMC]
- Han JW, Yoon JS, Jang SY. Short-term effects of topical cyclosporine A 0.05% (Restasis) in long-standing prosthetic eye wearers: a pilot study. Eye (Lond). 2014;28(10):1212-7. [Crossref] [PubMed] [PMC]
- Uçakhan Ö, Arslanturk-Eren M. The role of soft contact lens wear on meibomian gland morphology and function. Eye Contact Lens. 2019;45(5):292-300. [Crossref] [PubMed]
- Arita R, Itoh K, Inoue K, Kuchiba A, Yamaguchi T, Amano S. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology. 2009;116(3):379-84. [Crossref] [PubMed]
- Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, et al. Comparison of the long-term effects of various topical antiglaucoma medications on meibomian glands. Cornea. 2012;31(11):1229-34. [Crossref] [PubMed]
- Arita R, Itoh K, Maeda S, Maeda K, Furuta A, Tomidokoro A, et al. Effects of long-term topical anti-glaucoma medications on meibomian glands. Graefes Arch Clin Exp Ophthalmol. 2012;250(8):1181-5. [Crossref] [PubMed]
- Palamar M, Kiyat P, Yagci A. Dry eye and meibomian gland dysfunction in pseudophakic bullous keratopathy. Int Ophthalmol. 2019;39(2):393-6. [Crossref] [PubMed]
.: İşlem Listesi